Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of Progensa PCA3 test performance in post-oxytocin urine specimens
2010-024649-61Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oxytocin, sponsored by Radboud University Medical Center. Primary endpoint: Prostate cell yield in post-oxytocin urine vs spontaneous urine. Started Jan 2011; status: completed.
02
Drugs
oxytocin
Beyond the preview
Go deeper on 2010-024649-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024649-61.